Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,471.43p
   
  • Change Today:
    -53.57p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 937
  • Market Cap: £233.39m

Latest ShareCast News

BioVentix revenue, earnings rise in first half

By Josh White

Date: Monday 25 Mar 2024

(Sharecast News) - Monoclonal antibody specialist BioVentix reported a 13% rise in first-half revenue on Monday, to £6.7m, compared to £5.9m in the prior year.

Sunday share tips: Octopus Renewables Infrastructure Trust, Bioventix

By Alexander Bueso

Date: Sunday 19 Nov 2023

(Sharecast News) - The Financial Mail on Sunday's Midas column tipped the Octopus Renewables Infrastructure Trust to readers, pointing out its 7% dividend yield and the current valuation of its shares.

BioVentix revenue, profits improve in full-year results

By Josh White

Date: Monday 24 Oct 2022

(Sharecast News) - Diagnostic monoclonal antibody specialist BioVentix reported a 7% improvement in revenue in its full-year results on Monday, to £11.72m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,471.43p
Change Today -53.57p
% Change -1.18 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 937
Shares Issued 5.22m
Market Cap £233.39m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.42% below the market average98.42% below the market average98.42% below the market average98.42% below the market average98.42% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
82.01% above the market average82.01% above the market average82.01% above the market average82.01% above the market average82.01% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
30.99% below the market average30.99% below the market average30.99% below the market average30.99% below the market average30.99% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 23-Apr-2024

Time Volume / Share Price
14:26 100 @ 4,485.00p
14:16 245 @ 4,487.00p
14:00 340 @ 4,489.00p
13:19 1 @ 4,452.50p
11:20 1 @ 4,592.50p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page